Are Calcium Channel Blockers Related to Lung Cancer?
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Scragg R, Glover M
. Parental and adolescent smoking: does the association vary with gender and ethnicity?. N Z Med J. 2007; 120(1267):U2862.
View
2.
Manasirisuk P, Chainirun N, Tiamkao S, Lertsinudom S, Phunikhom K, Sawunyavisuth B
. Efficacy of Generic Atorvastatin in a Real-World Setting. Clin Pharmacol. 2021; 13:45-51.
PMC: 7943322.
DOI: 10.2147/CPAA.S285750.
View
3.
Jick H, Jick S, Derby L, Vasilakis C, Myers M, Meier C
. Calcium-channel blockers and risk of cancer. Lancet. 1997; 349(9051):525-8.
DOI: 10.1016/S0140-6736(97)80084-0.
View
4.
Cote M, Liu M, Bonassi S, Neri M, Schwartz A, Christiani D
. Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium. Eur J Cancer. 2012; 48(13):1957-68.
PMC: 3445438.
DOI: 10.1016/j.ejca.2012.01.038.
View
5.
Michels K, Rosner B, Walker A, Stampfer M, Manson J, Colditz G
. Calcium channel blockers, cancer incidence, and cancer mortality in a cohort of U.S. women: the nurses' health study. Cancer. 1998; 83(9):2003-7.
View